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Background: Psychotropic drug prescribing is problematic and knowledge of factors affecting the initiation and
maintenance of such prescribing is incomplete. Such knowledge could provide a basis for the design of
interventions to change prescribing patterns for psychotropics. The aim of this study was to explore the views of
general practitioners (GPs), GP interns, and heads of primary care units on factors affecting the prescribing of
psychotropic drugs in primary care.
Methods: We performed four focus group discussions in Gothenburg, Sweden, with a total of 21 participants (GPs,
GP interns, and heads of primary care units). The focus group discussions were transcribed verbatim and analyzed
using manifest content analysis.
Results: Three different themes emerged from the focus group discussions. The first theme Seeking care for
symptoms, reflects the participants’ understanding of why patients approach primary care and comprised categories
such as knowledge, attitudes, and society and the media. The second theme, Lacking a framework, resources, and
treatment alternatives, which reflects the conditions for the physician-patient interaction, comprised categories such
as economy and resources, technology, and organizational aspects. The third theme, Restricting or maintaining
prescriptions, with the subthemes Individual factors and External influences, reflects the physicians’ internal decision
making and comprised categories such as emotions, knowledge, and pharmaceutical industry.
Conclusion: The results of the present study indicate that a variety of factors may affect the prescribing of
psychotropic medications in primary care. Many factors were related to characteristics of the patient, the physician
or their interaction, rather than the patients’ medical needs per se. The results may be useful for interventions to
improve psychotropic prescribing in primary care.
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The use of psychotropics is increasing both internationally
[1] and in Sweden [2], and the majority of these drugs are
prescribed in primary care [3-5]. The drug group psychotro-
pics include antidepressants, anxiolytics/hypnotics, mood
stabilizers, and antipsychotics, which are all used to treat
psychiatric disorders. While the use of psychotropics confers
many benefits and is sometimes life-saving, it is also associ-
ated with problems of dependency, medicalization and side-* Correspondence: tove.hedenrud@socmed.gu.se
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reproduction in any medium, provided the oreffects. Elderly people are particularly sensitive to side-
effects, and the risk increases with the number of drugs
used. In fact, withdrawal of psychotropics among these
patients has been reported to improve cognition and to
reduce the incidence of falls [6]. In the Region Västra
Götaland in western Sweden, the prescribing of psycho-
tropics is extensive compared to other parts of the
country [7]. In this region, a high proportion of elderly
people also use three or more psychotropics concur-
rently, a measure considered an indicator of problem-
atic prescribing [7].
For these reasons, there may be a need for interven-
tions aimed at limiting prescriptions of psychotropics toral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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guably, as polypharmacy may be a problem in itself, such
interventions should target the prescribing of psychotro-
pics in general, rather than that of specific drug groups.
Consequently, knowledge is needed about factors that can
influence the prescribing of this drug group as a whole.
Previous qualitative studies, however, have only inves-
tigated physician decision making concerning specific
psychotropic drug groups, such as hypnotics [8], antide-
pressants [9,10], and anxiolytics [11]. One quantitative
study set out to establish if there was an association be-
tween physician characteristics (e.g. physician age or
practice size) and prescribing of psychotropic medication
[12], but the authors concluded that this particular pre-
scribing is hard to predict. Further, previous research has
mostly been focused on the initiation of psychotropic
drugs. There appears to be a lack of a comprehensive ana-
lysis of factors affecting all prescribing of psychotropics
in primary care, that is, both initiation and maintenance
of prescriptions. Therefore, the aim of this study was to
explore the views of general practitioners (GPs), GP in-
terns, and heads of primary care units on factors affect-
ing the prescribing of psychotropic drugs in general in
primary care.
Methods
Focus group interviews are appropriate to use when the
goal is to explore people’s knowledge and experiences
[13]. Data collection was performed in four focus groups
consisting of GPs, GP interns, and heads of primary
health care units (Table 1). A GP in Sweden is a phys-
ician with a 5-year specialist training in family medicine,
whereas a GP intern is a trainee within this specialty.
The heads of the units have the overall financial respon-
sibility for a primary care unit, which includes costs for
prescribed drugs. Recruitment of participants was performed
by two of the authors (S.A.S., S.M.W.), by approaching per-
sonal contacts by e-mail and by telephone. In all, 65 persons
were approached and 21 agreed to participate and were
included in the study (Table 1). The most commonly
stated reason for declining participation was a lack of
time. A letter was sent 1 week before each focus groupTable 1 Characteristics of focus groups
Focus group I
Participants GPs
Number of participants (number of women) 4 (1)
Moderator T.M.H
Assistant moderator S.A.S
Coding of meaning units T.M.H & S.A.S
GP general practitioner.
T.M.H. Tove M. Hedenrud.
S.A.S. Staffan A. Svensson.
S.M.W. Susanna M. Wallerstedt.discussion was scheduled, containing detailed partici-
pant information.
The focus group discussions were performed in 2011
at two different health care units in Gothenburg (a city
of about 600,000 inhabitants). Apart from the partici-
pants and the moderator, one additional researcher took
part as an assistant moderator, taking field notes. We
chose to alternate between moderators in the focus groups
because we believed that our different backgrounds could
have an impact on the discussions. The researcher with
the most experience of focus groups (T.M.H.: pharmacist,
Ph.D.) was moderator twice and the other two re-
searchers acted as moderators once (S.A.S.: GP intern,
Ph.D.; S.M.W.: clinical pharmacologist, Ph.D.). The study
protocol was approved by the Regional Ethical Review
Board in Gothenburg, Sweden.
Each group discussion started with a short, structured
introduction by the moderator, and participant informa-
tion was again distributed to each person together with
a consent form to be signed before the discussion started.
To facilitate the discussion, we used an interview guide
(Table 2) [13], including two fictitious patient cases. Each
focus group lasted between 1.5 and 2 hours. The discus-
sions were recorded on a digital voice recorder. After the
fourth group, the research group agreed that no new
factors had emerged and data saturation was attained.
The focus group discussions were transcribed verbatim
and all transcripts were read by all researchers. Names
of participants were replaced by codes (fictitious initials).
NVivo 9 software was used for data management. We
used manifest content analysis, according to Graneheim
and Lundman [14], which is an analysis of what the text
says rather than what the text talks about (latent content
analysis). For each focus group, meaning units were
identified, extracted, condensed, and assigned a descrip-
tive code by two researchers independently (Table 1). In
the next step, these two researchers met and discussed
all codes for that particular focus group until consensus
was reached. The three researchers together then sorted
the various codes, for all four focus groups, into categories.
The categories were discussed at a seminar with other quali-
tative researchers. As a last step, we identified emergentFocus group II Focus group III Focus group IV
Heads of units GPs and GP interns GP interns
5 (5) 5 (3) 7 (1)
T.M.H S.A.S S.M.W.
S.M.W. T.M.H T.M.H
T.M.H & S.M.W. S.A.S & S.M.W. T.M.H & S.M.W.
Table 2 Interview guide used in focus groups
Opening question (to each participant) • Please tell us your name and where you work.
Introductory questions • To what extent is the prescribing of psychotropic drugs discussed in your work places?
• Going back to when you first started to work as a physician (Focus group II: to work in health care),
what has been the view on the prescribing of psychotropics through the years?
Transition questions • What are the difficulties with prescribing psychotropics compared to other medicines?
• The prescribing of psychotropic drugs varies in our country. What is your view on that?
• What do you think affects the prescribing of psychotropic drugs?
Key questions • Participants were presented with two fictitious case scenarios, concerning patients with complex
clinical problems, partly involving psychotropics and were asked to comment.
Ending questions • You have discussed different factors affecting the prescribing of psychotropic drugs. Which factor
do you think is the most important?
• Summary of the discussions by the assistant moderator, followed by the question: How well does
this capture what has been discussed?
• Have we forgotten anything?
• If time allowed, we asked: We will perform more focus group discussions. In what way do you think
the current set-up could be improved?
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ing on an interpretative level [14]. Throughout the
process of analysis, any disagreements were resolved
through discussions.
Results
The focus groups and participants are described in
Table 1. The heads of the units were all female nurses
without the right to prescribe drugs. The rest of the par-
ticipants were physicians, who, in Sweden, have an unre-
stricted right to prescribe drugs. In the mixed groupFigure 1 Factors of importance for psychotropic prescribing, resulting(focus group 3), there were 2 GPs and 3 GP interns.
Three different themes emerged from the focus groups:
Seeking care for symptoms; Lacking a framework, resources,
and treatment alternatives; and Restricting or maintaining
prescriptions. The latter had two subthemes: Individual
factors and External influences. The themes and categories
(in alphabetical order) are presented in Figure 1. The re-
sults describe the prescribing of psychotropic medica-
tion as a process, from patient care seeking to the actual
prescribing. The first theme reflects the participants’
understanding of why patients approach primary care,themes and categories.
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interaction, and the third one the physicians’ internal
decision making. All four focus groups contributed to
all themes, but for four out of 21 categories there were
contributions from only two or three focus groups. The
presented quotes were chosen to represent a certain
category, that is, to exemplify the discussions in the
focus groups.
Seeking care for symptoms
This theme contains categories describing factors of im-
portance for the decision of the patient to seek care for
psychiatric symptoms. According the participants, seeking
care was not synonymous, for all patients, with wanting
medication.
Demography and social factors were considered import-
ant for care seeking. Unemployment, divorce, and social
problems were brought up as factors of importance. Age
was also discussed and the participants meant that youth
today cannot handle disappointments and they have high
expectations on quick solutions.
“… young people who can’t feel bad for 1 day, just have
to get well the same day.” (Focus group II, Head 1)
The participants discussed the importance of society
and the media in terms of how mental diseases are less
stigmatized today. The participants perceived that patients
do not consider psychiatric symptoms to be as disgraceful
as before, and they are more prone to try a psychotropic
medication. They also mentioned that the media are con-
tributing to the idea of antidepressants as “the happy pill”
and that there is increased medicalization in society.
“… the main difference that distinguish psychotropics,
and psychiatric diseases as well, is that psychiatric diseases
have traditionally somehow, for both health care and
patients, been kind of shameful. And that is disappearing
to some extent.” (Focus group IV, GP intern 4)
Other influences mentioned were positive or negative
experiences of medication of friends and relatives, but
also staff at nursing homes who may demand treatment
for a patient who is considered problematic. The impact
of knowledge (the well-informed patient) and attitudes of
patients (e.g., a general skepticism against medication)
were also discussed.
“So sometimes I meet people who are negative from
the start and they are pretty difficult to convince. And
sometimes they finally give in and try for a week. And
then they go, All right, it didn’t work. Even though
I’ve explained that it may take 3 weeks.” (Focus
group III, GP 5)Lacking a framework, resources, and treatment alternatives
The categories in this theme deal with the conditions of the
physician patient consultation. Many of the factors men-
tioned were considered barriers to rational prescribing.
The category characteristics of mental illness included
difficulties of psychiatric compared with somatic diseases,
e.g., diagnosing, where the participants meant there may
be a risk of imprecise diagnosing. Further, participants
perceived problems in evaluating treatment. The problem
of keeping psychiatric treatment evidence-based was also
highlighted.
“…psychiatry is not a science like others, not as exact.
And it leaves room for many interpretations.” (Focus
group I, GP 1)
“It depends a lot on the individual, so it’s hard to
comply with general guidelines. Each time you have to
manage by trial and error, I would say. And that
applies to the drug, the selection, and the dosage as
well.” (Focus group IV, GP intern 5)
The patient physician process comprised the importance
of communication skills, e.g. the ability of the physician to
ask the right questions in order to make the right diagno-
sis. Further, the participants discussed patient factors, such
as the patients’ pre-understanding, or fear of adverse
effects, as well as their expectations and desires concerning
treatment.
“There are lots of people who expect that they have
the right to feel well all their lives and that health care
should sort it out for them.” (Focus group I, GP 2)
Concerning economy and resources, the costs of medi-
cation and engaging locum physicians in primary care
were mentioned. Further, the lack of time was discussed
both with regard to the patient physician consultation
and concerning patient follow-up.
Another category was technology. According to the partic-
ipants, technical issues may increase the issue of renewing
prescriptions without proper evaluation of the treatment.
“It’s easy to press the button, to click accept.” (Focus
group I, GP 1)
(In the multi-dose drug dispensing system in Sweden
(ApoDos), all drugs prescribed to an individual can be
renewed simultaneously by performing “one click” on the
computer. Ordinary prescriptions, on the other hand, need
to be renewed one by one. Authors’ comment)
Two organizational aspects were considered import-
ant for the prescribing of psychotropics; namely, level
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between care units concerned primarily different pre-
scribing traditions at different units. The problem of
indeterminate boundaries between psychiatry and pri-
mary care, the transfer to primary care of patients pre-
viously treated within psychiatric care implicating the
inheritance of prescriptions from psychiatry, and the
limited possibilities for follow-up in primary care were
some of the subcategories of level of care.
“Because then you think, if they end up in the right
place perhaps it’ll be the right medication and you’re
more in control of things. And that’s what it’s all
about. As for me, I feel that a lot of this is an
organiza-, well, perhaps that’s stretching it a bit, but
to some extent anyway, that this is an organizational
issue to a large extent, that there are lots of
prescriptions.” (Focus group II, Head 2)
The participants also discussed treatment alternatives
from two perspectives, namely, effects/side-effects and
availability. Based on the perceived effect of treatment,
the choice between pharmacotherapy and psychother-
apy is influenced by disease severity, as well as patient’s
background and age. Further, the participants sug-
gested that limited access to psychotherapy can increase
pharmacotherapy treatment.
“No psychoanalyst and no God to offer. We just have
that security blanket, the pill, you know…” (Focus
group IV, GP intern 6)Restricting or maintaining prescriptions
The last theme describes how the prescribing behavior
of physicians is influenced by Individual factors and
External influences.
The category emotions comprised aspects such as the
wish to be, or not to be, updated on new psychotropic
drugs, not having the energy to say no to a patient, or
the unease about changing drug treatment initiated by
colleagues, e.g., specialists in psychiatry:
“It’s much harder to withdraw a drug. And if
someone else has started it, I feel, Hang on, I’m
stepping on this colleague’s toes.” (Focus group III,
GP 6)
Knowledge, or, rather, lack of knowledge, was another
category described to influence the prescribing of psycho-
tropics. The participants mentioned that primary care
physicians do not have enough knowledge about new or
specialized psychotropics to prescribe them or to evaluate
their effect.“…we’ve got problems getting help when we feel we’re
not quite, don’t have the right competence…//…So I
gather we all feel that our knowledge is not sufficient
from time to time, for the prescribing we’re doing.”
(Focus group I, GP 3)
Participants related the experience that a physician’s
past prescribing behavior may affect his or her future pa-
tient clientele. Participants mentioned that low prescrib-
ing of benzodiazepines makes those patients seek care
elsewhere. Further, the experience of physicians makes
them prescribe a small range of psychotropics, i.e., they
have their own personal prescribing repertoire.
The impact of medical education was also discussed
among the participants and many of the participating
physicians had gone to medical school at the University
of Gothenburg. They said it was their experience that in
that academic environment, medication, rather than
non-pharmacological treatment, was advocated.
“… those of us who studied in Gothenburg have had it
thoroughly hammered in that it’s the drugs that
matter.” (Focus group IV, GP intern 7)
Variability in prescribing between individuals was men-
tioned, with several examples of high prescribers given,
that is, physicians that the participants had met in prac-
tice. Further, psychiatrists as a group were described as
prescribing psychotropics to a higher extent and in higher
doses compared to GPs. Participants also felt that the pre-
scribing of psychotropics is often arbitrary.
“We just tinker about with the levels of different
chemicals. And then we hope and keep our fingers
crossed for it to work, and sometimes it’s for the
worse.” (Focus group IV, GP intern 8)
External factors of importance are the pharmaceutical
industry, colleagues, and the health care authorities.
The category health care authorities mainly concerned
regional prescribing guidelines and the list of recommended
drugs prepared by the drug and therapeutics committees.
These publications were mostly regarded as trustworthy by
the participants while some colleagues and, in particular,
the drug industry were seen as less dependable.
Discussion
In this focus group study, we explored the views of GPs,
GP interns, and heads of primary care units on factors
affecting the prescribing of psychotropic drugs in general
in primary care. Interestingly, many factors emerged
other than the medical needs of the patient; the results
indicate that prescribing of psychotropics may be initi-
ated or maintained due to patient or peer pressure, or
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ther, the importance of the characteristics of mental ill-
ness was more obvious in our study than in previous
research in this area [8-11]. Psychiatry was depicted as a
more imprecise field than other specialties. For this rea-
son, psychiatric treatment was considered harder to keep
evidence-based, and to require individual considerations
to a greater extent. These views on differences between
psychiatric and somatic diseases may indicate a percep-
tion of lack of scientific knowledge in general in psych-
iatry, but may also indicate a perceived lack of personal
knowledge among the participants.
Emotions were involved in both restricting, and initiat-
ing and maintaining prescriptions of psychotropic drugs.
The experienced pressure from patients or from col-
leagues was described in terms of emotions such as not
having the energy to argue with the patient, or the fear
of stepping on a colleague’s toes. Indeed, previous re-
search has shown that little effort is used to form a
second opinion on a patient’s problem when psycho-
tropic drug treatment has been initiated by another
doctor [15]. The dilemma of pressure from patients has
been described previously [9,15-17], as has the diffi-
culty in finding a balance between rational prescribing
and consideration of each patient’s problems [16]. Re-
cently, a hypothesis on emotional prescribing was formu-
lated as an attempt to explain inappropriate or irrational
prescribing, and the need for further research on this type
of prescribing was emphasized [18].
The problem of indeterminate boundaries between
primary care and psychiatry was another recurrent topic.
In Sweden, the level of care depends on the type of psy-
chiatric disease as well as the severity of the disease.
Thus, psychosis and severe depression are predomin-
antly treated in psychiatry, whereas mild depression and
anxiety are often treated in primary care. Clearly, many
patients will fall in-between, and it may be difficult to
assign these to the appropriate level of care. The partici-
pants described referral blocking of patients to psych-
iatry, on the one hand, and the transfer to primary care
of patients previously treated within psychiatric care, on
the other. These boundaries create frustration and add-
itional work for the GPs. The takeover of previous pre-
scriptions from specialists has been highlighted previously,
but it is not always described as a problem [15]. For
instance, it could be perceived as a way to reduce the
physician’s responsibility [15]. Also, it may have the
positive effect of saving time for the practitioner.
Technology has made it possible to renew a number
of prescriptions by using a single mouse click, and doing
so may be one way of reducing the perceived high work-
load of GPs. Indeed, this possibility may increase the
overall prescribing of psychotropics, as reported in a
recent Swedish study [19]. Further, the time constraintsfor consultation and their effect on prescribing have been
described in previous studies [8,9,11,16]. One study even
suggested that changing how doctors use their time
would be a better intervention than ’bombarding” them
with pharmacological information or encouraging them
to change prescribing practices [16].
Strengths and limitations
We believe that the mix of participants is a strength of
the study. The physicians’ workplaces were spread across
the city, covering both the city center and the suburbs,
thus representing care for different socio-economic groups.
Furthermore, the heads of units contributed with a top-
down perspective. However, we had no participants from
rural areas. In addition, the fact that we recruited by per-
sonal contacts may have introduced a source of bias. Thus,
there may be some aspects on prescribing of psychotropics
that we may not have captured.
In this study, we chose to elicit a discussion about psy-
chotropic prescribing in the widest sense. An alternative
strategy would have been to focus on certain drug groups
(e.g. anxiolytics), or on specific aspects of prescribing (e.g.
initiation or maintenance). Our reasons for this choice
was, first, the lack of research on psychotropics as a group,
and, second, our belief that a more universal approach will
be more useful in the design of interventions aimed at in-
creasing the quality of prescribing.
We chose to use three different moderators and we
cannot rule out that this choice may have had an impact
on the results. In addition, one of the researchers had
the dual role of a GP intern and a researcher. However,
the three moderators followed the same interview guide
and were all careful not to steer the discussion, e.g., by
not responding in an encouraging way to any one of the
comments of the participants [13]. We therefore believe
that the composition of participants was more important
for the dynamics of the discussion in each focus group.
Conclusions
This study illustrates the complexity of the process of
psychotropic prescribing. Numerous factors are import-
ant in this process, many of which are unrelated to the
patient’s medical needs. The results may be useful when
targeting interventions aimed at improved prescribing of
psychotropics in primary care.
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